Chronic cough, persisting for more than eight weeks, poses a significant diagnostic and therapeutic challenge in clinical practice. This article aims to provide a comprehensive approach to managing this common yet complex condition.
Chronic cough is often a symptom of underlying conditions such as gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS). It could also be idiopathic in nature. The pathophysiology involves a hypersensitive cough reflex triggered by inflammation and neuronal changes.
Initial evaluation should aim to identify common causes using a thorough history, physical examination, and basic investigations such as chest X-ray and spirometry. If the cause remains elusive, further investigations including high-resolution computed tomography, bronchoscopy, and esophageal pH monitoring may be warranted.
Treatment should be tailored to the underlying cause. For GERD-induced cough, proton pump inhibitors are recommended. Inhaled corticosteroids are beneficial in asthma-related cough, while antihistamines and decongestants may help in UACS. If the cough is idiopathic, neuromodulators such as gabapentin can be considered.
In refractory cases, a multi-disciplinary approach involving pulmonologists, gastroenterologists, and otolaryngologists may be necessary. Cognitive-behavioral therapy has also shown promise in managing chronic refractory cough.
Chronic cough management requires a systematic and comprehensive approach. Identifying the underlying cause is crucial to guide treatment. In refractory cases, a multi-disciplinary approach and novel therapies may be required. Continued research is needed to better understand the pathophysiology and to develop more effective treatment strategies.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation